Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "A07" (142)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Amphotericin B (A07AA07) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Ampho-Moronal
20 Tablet(s)
11.20
28.60
10 %
Tablets: Amphotericinum B 100 mg
Dermapharm AG
B / SL
FB
G
IP
CI
Ampho-Moronal
24 ml
8.68
25.85
10 %
Suspension zur Anwendung in der Mundhöhle/zum Einnehmen: Amphotericinum B 100 mg/ml
Dermapharm AG
B / SL
FB
G
Fidaxomicin (A07AA12) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
PP
Dificlir
20 Tablet(s)
1356.53
1491.70
10 %
Coated tablets: Fidaxomicinum 200 mg
Tillotts Pharma AG
A / SL
FB
G
Medicinal Charcoal (A07BA01) 4 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Ph
Arkocaps charbon végétal
45
k.A.
Capsules: Carbo Activatus 225 mg
Arko Diffusion AG
D
FB
G
CI
Carbovit
100 ml
k.A.
Suspension (oral): Carbo Activatus 15 g
Cyntos AG
D
FB
G
IP
CI
Norit
30 Capsule(s)
k.A.
Capsules: Carbo Activatus 200 mg
APS-Arzneimittel-
Parallelimport-
Service AG
D
FB
G
IP
CI
Ph
CM
Phytopharma Charbon
végétal
30 Capsule(s)
k.A.
Capsules: Carbo Activatus 225 mg
Arko Diffusion AG
D
FB
G
Medicinal Charcoal, Combinations (A07BA51) 4 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Carboticon
30 x 2 Capsule(s)
6.79
12.55
k.A.
Capsules: 2 Active Agents
Capsules: 2 Active Agents
Leman SKL SA
D
FB
G
IP
CI
Carbolevure
20 Capsule(s)
12.15
k.A.
Kapseln für Erwachsene: 2 Active Agents
Pierre Fabre Pharma SA
D
FB
G
IP
CI
Carbolevure
30 Capsule(s)
16.45
k.A.
Kapseln für Erwachsene: 2 Active Agents
Pierre Fabre Pharma SA
D
FB
G
IP
CI
Carbolevure
20 Capsule(s)
9.85
k.A.
Kapseln für Kinder: 2 Active Agents
Pierre Fabre Pharma SA
D
FB
G
Oral Rehydration Salt Formulations (A07CA) 3 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Elotrans
20 Sachet(s)
4.58
8.45
10 %
Pulver zur Herstellung einer Lösung zum Einnehmen: 4 Active Agents
Helvepharm AG
● 
D / SL
FB
G
IP
CI
Normolytoral
10 Sachet(s)
4.37
8.05
k.A.
Pulver zur Herstellung einer Lösung zum Einnehmen im Beutel: 4 Active Agents
Gebro Pharma AG
D
FB
G
IP
CI
Oralpädon Erdbeere
10
k.A.
Pulver zur Herstellung einer Lösung zum Einnehmen: 2 Active Agents
Spirig HealthCare AG
D
FB
G
Loperamide (A07DA03) 21 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Imodium
‐
I
-
T
20 Capsule(s)
3.87
6.85
20 %
Capsules: Loperamidi Hydrochloridum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / SL / SO
FB
G
IP
CI
Imodium
-
T
60 Capsule(s)
9.40
26.60
20 %
Capsules: Loperamidi Hydrochloridum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
B / SL / SO
FB
G
IP
CI
Loperamid Streuli 2 mg
20 Capsule(s)
3.48
6.45
10 %
Loperamidi Hydrochloridum 2 mg
Streuli Pharma AG
D / SL / SG
FB
G
IP
CI
Loperamid Streuli 2 mg
60 Capsule(s)
8.59
25.75
10 %
Loperamidi Hydrochloridum 2 mg
Streuli Pharma AG
B / SL / SG
FB
G
IP
CI
Loperamid lingual Spirig HC
20
3.48
6.45
10 %
Melting tablets: Loperamidi Hydrochloridum 2 mg
Spirig HealthCare AG
D / SL / SG
FB
G
IP
CI
Loperamid lingual Spirig HC
60
7.93
25.10
10 %
Melting tablets: Loperamidi Hydrochloridum 2 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
CM
Loperamid Spirig HC 2 mg
20 Tablet(s)
3.48
6.45
10 %
Coated tablets: Loperamidi Hydrochloridum 2 mg
Spirig HealthCare AG
D / SL / SG
FB
G
IP
CI
CM
Loperamid Spirig HC 2 mg
60 Tablet(s)
7.93
25.10
10 %
Coated tablets: Loperamidi Hydrochloridum 2 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Loperamid-Mepha 2
‐
I
20 Tablet(s)
3.48
6.45
10 %
Coated tablets: Loperamidi Hydrochloridum 2 mg
Mepha Pharma AG
● 
D / SL / SG
FB
G
IP
CI
Loperamid-Mepha 2
‐
I
60 Tablet(s)
7.88
25.00
10 %
Coated tablets: Loperamidi Hydrochloridum 2 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
CI
CM
Loperamid Sandoz
20 Capsule(s)
3.48
6.45
10 %
Capsules: Loperamidi Hydrochloridum 2 mg
Sandoz
Pharmaceuticals AG
D / SL / SG
FB
G
IP
CI
CM
Loperamid Sandoz
60 Capsule(s)
8.59
25.75
10 %
Capsules: Loperamidi Hydrochloridum 2 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Imodium lingual
-
T
20 Tablet(s)
8.05
15.50
k.A.
Melting tablets: Loperamidi Hydrochloridum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
CI
Imodium lingual akut
12
k.A.
Melting tablets: Loperamidi Hydrochloridum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
CI
Loperam-X lingual
20
k.A.
Melting tablets: Loperamidi Hydrochloridum 2 mg
axapharm ag
D
FB
G
IP
CI
Loperamid-Mepha lingual 2 mg
20
k.A.
Melting tablets: Loperamidi Hydrochloridum 2 mg
Mepha Pharma AG
D
FB
G
IP
CI
CM
Amavita Loperamid 2 mg
20 Capsule(s)
k.A.
Capsules: Loperamidi Hydrochloridum 2 mg
Amavita Health Care AG
D
FB
G
IP
CI
CM
SUN STORE Loperamid 2 mg
20
k.A.
Capsules: Loperamidi Hydrochloridum 2 mg
Sun Store Health Care AG
D
FB
G
IP
CI
Imodium lingual akut
10
k.A.
Melting tablets: Loperamidi Hydrochloridum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
CI
Lopimed
20 Capsule(s)
5.23
9.65
k.A.
Capsules: Loperamidi Hydrochloridum 2 mg
Sandoz
Pharmaceuticals AG
C
FB
G
IP
CI
Lopimed
60 Capsule(s)
12.15
26.20
k.A.
Capsules: Loperamidi Hydrochloridum 2 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Loperamide, Combinations (A07DA53) 3 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Imodium duo
12
k.A.
Tablets: 2 Active Agents
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
CI
Imodium duo
18
k.A.
Tablets: 2 Active Agents
JNTL Consumer Health II
(Switzerland) GmbH
FB
G
IP
CI
Imodium duo
8 Tablet(s)
k.A.
Tablets: 2 Active Agents
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
Budesonide (A07EA06) 23 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Entocort CIR 3 mg
20 Capsule(s)
19.11
36.70
10 %
Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg
Tillotts Pharma AG
B / SL / SO
FB
G
IP
CI
Entocort CIR 3 mg
50 Capsule(s)
47.76
67.10
10 %
Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg
Tillotts Pharma AG
B / SL / SO
FB
G
IP
CI
Entocort CIR 3 mg
100 Capsule(s)
95.39
117.60
10 %
Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg
Tillotts Pharma AG
B / SL / SO
FB
G
IP
CI
Budesonid Spirig HC 3 mg
20
11.08
28.45
10 %
Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Budesonid Spirig HC 3 mg
50
27.54
46.35
10 %
Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Budesonid Spirig HC 3 mg
100
53.68
74.80
10 %
Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Budenofalk 2 mg
14 piece(s)
79.18
102.55
10 %
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Budenofalk 2 mg
2 x 14 piece(s)
146.76
176.05
10 %
Dr. Falk Pharma AG
B / SL
FB
G
L
IP
CI
Entocort Enema
Kombipackung(en)
40.89
60.90
10 %
Enema: Budesonidum 2.3 mg
Enema: Budesonidum 2mg / 100ml
Tillotts Pharma AG
● 
B / SL
FB
G
L
IP
CI
Jorveza 1 mg
20
71.22
93.85
10 %
Melting tablets: Budesonidum 1 mg
Dr. Falk Pharma AG
B / SL
FB
G
L
IP
CI
Jorveza 1 mg
60
213.65
248.75
10 %
Melting tablets: Budesonidum 1 mg
Dr. Falk Pharma AG
B / SL
FB
G
L
IP
CI
Cortiment MMX 9mg
30
86.47
110.45
10 %
Delayed release tablets: Budesonidum 9 mg
Ferring AG
B / SL
FB
G
IP
CI
Budenofalk 3 mg
50 Capsule(s)
49.70
69.10
10 %
Capsules: Budesonidum 3 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Budenofalk 3 mg
100 Capsule(s)
93.62
115.75
10 %
Capsules: Budesonidum 3 mg
Dr. Falk Pharma AG
B / SL
FB
G
L
IP
CI
Jorveza 0.5 mg
20
62.04
83.90
10 %
Schmeltabletten: Budesonidum
Dr. Falk Pharma AG
B / SL
FB
G
L
IP
CI
Jorveza 0.5 mg
90
279.17
320.05
10 %
Schmeltabletten: Budesonidum
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Budenofalk 4 mg
12
75.19
98.20
10 %
Zäpfchen: Budesonidum 4 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Budenofalk 4 mg
60
323.32
368.05
10 %
Zäpfchen: Budesonidum 4 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Budenofalk Uno 9 mg
20 Sachet(s)
60.39
82.10
10 %
magensaftresistentes Granulat: Budesonidum 9 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Budenofalk Uno 9 mg
60 Sachet(s)
180.62
212.85
10 %
magensaftresistentes Granulat: Budesonidum 9 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Kinpeygo 4 mg
28
k.A.
Hartkapseln mit veränderter Wirkstofffreisetzung: Budesonidum 4 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Kinpeygo 4 mg
120
k.A.
Hartkapseln mit veränderter Wirkstofffreisetzung: Budesonidum 4 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Jorveza 1 mg
90
k.A.
Melting tablets: Budesonidum 1 mg
Dr. Falk Pharma AG
B
FB
G
Mesalazine (A07EC02) 40 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
Salofalk 500
20 suppositories
14.46
32.05
10 %
Suppositories: Mesalazinum 500 mg
Dr. Falk Pharma AG
B / SL / SO
FB
G
L
IP
CI
Salofalk 500
50 suppositories
30.41
49.25
10 %
Suppositories: Mesalazinum 500 mg
Dr. Falk Pharma AG
B / SL / SO
FB
G
L
IP
CI
Salofalk 1 g
10 suppositories
21.70
39.85
10 %
Suppositories: Mesalazinum 1000 mg
Dr. Falk Pharma AG
B / SL / SO
FB
G
L
IP
CI
Salofalk 1 g
30 suppositories
65.10
86.75
10 %
Suppositories: Mesalazinum 1000 mg
Dr. Falk Pharma AG
B / SL / SO
FB
G
L
IP
CI
Salofalk 1 g
60 suppositories
114.57
140.20
10 %
Suppositories: Mesalazinum 1000 mg
Dr. Falk Pharma AG
B / SL / SO
FB
G
L
IP
CI
Yaldigo 500 mg
20
12.79
30.35
10 %
Suppositories: Mesalazinum
Tillotts Pharma AG
B / SL / SG
FB
G
L
IP
CI
Yaldigo 500 mg
50
26.91
45.70
10 %
Suppositories: Mesalazinum
Tillotts Pharma AG
B / SL / SG
FB
G
L
IP
CI
Yaldigo 1 g
10
19.20
37.30
10 %
Suppositories: Mesalazinum 1 g
Tillotts Pharma AG
B / SL / SG
FB
G
L
IP
CI
Yaldigo 1 g
30
57.60
79.05
10 %
Suppositories: Mesalazinum 1 g
Tillotts Pharma AG
B / SL / SG
FB
G
L
IP
CI
Yaldigo 1 g
60
101.38
126.65
10 %
Suppositories: Mesalazinum 1 g
Tillotts Pharma AG
B / SL / SG
FB
G
IP
CI
Mezavant, 1,2 g
magensaftresistente
Retardtabletten
60
47.32
67.90
10 %
Mesalazinum 1.2 g
Takeda Pharma AG
B / SL
FB
G
IP
CI
Pentasa Klysma
7 Enema(s)
17.99
36.00
10 %
Ferring AG
B / SL
FB
G
IP
CI
Salofalk 1000 mg
14
28.95
47.90
10 %
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 1000 mg
50 Sachet(s)
45.04
65.40
10 %
Granulate: Mesalazinum 1 g
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 1000 mg
150 Sachet(s)
114.86
141.35
10 %
Granulate: Mesalazinum 1 g
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 1.5 g
60 Sachet(s)
75.10
98.10
10 %
Granulate: Mesalazinum 1.5 g
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 3 g
30 Sachet(s)
78.06
101.30
10 %
Granulate: Mesalazinum 3000 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 3 g
90
199.05
232.90
10 %
Granulate: Mesalazinum 3000 mg
Dr. Falk Pharma AG
B / SL
FB
G
L
IP
CI
Pentasa
28 suppositories
39.81
60.80
10 %
Suppositories: Mesalazinum 1 g
Ferring AG
B / SL
FB
G
IP
CI
Asacol 400
100 Tablet(s)
29.01
47.95
10 %
Coated tablets: Mesalazinum 400 mg
Medinova AG
B / SL
FB
G
IP
CI
Asacol 800
48 Tablet(s)
25.87
44.55
10 %
Coated tablets: Mesalazinum 800 mg
Medinova AG
B / SL
FB
G
IP
CI
Salofalk 250
100 Tablet(s)
23.20
41.65
10 %
Coated tablets: Mesalazinum 250 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 500
100 Tablet(s)
38.31
58.10
10 %
Coated tablets: Mesalazinum 500 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 1 g
20
13.00
30.55
10 %
Coated tablets: Mesalazinum 1000 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 1 g
100
64.97
87.05
10 %
Coated tablets: Mesalazinum 1000 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Yaldigo 1600 mg
60
60.09
81.75
10 %
Gastric juice resistant tablets: Mesalazinum 1600 mg
Tillotts Pharma AG
B / SL
FB
G
IP
CI
Pentasa 1g
50 Sachet(s)
36.20
55.80
10 %
Depot-Granulat: Mesalazinum 1 g
Ferring AG
B / SL
FB
G
IP
CI
Pentasa 1g
150 Sachet(s)
103.07
128.50
10 %
Depot-Granulat: Mesalazinum 1 g
Ferring AG
B / SL
FB
G
IP
CI
Pentasa 2g
60 Sachet(s)
78.21
101.45
10 %
Depot-Granulat: Mesalazinum 2 g
Ferring AG
B / SL
FB
G
IP
CI
Pentasa 500 mg
100 Tablet(s)
29.56
48.55
10 %
Depot-Tabletten: Mesalazinum 500 mg
Ferring AG
B / SL
FB
G
IP
CI
Pentasa 500 mg
300 Tablet(s)
88.01
112.15
10 %
Depot-Tabletten: Mesalazinum 500 mg
Ferring AG
B / SL
FB
G
IP
CI
Pentasa 1g
60 Tablet(s)
28.86
47.80
10 %
Depot-Tabletten: Mesalazinum 1 g
Ferring AG
B / SL
FB
G
IP
CI
Salofalk 2 g
7 Enema(s)
22.15
40.50
10 %
lavements: Mesalazinum 2 g
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 4 g
7 Enema(s)
35.41
54.95
10 %
lavements: Mesalazinum 4 g
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 250
30 suppositories
k.A.
Suppositories: Mesalazinum 250 mg
Dr. Falk Pharma AG
B
FB
G
IP
CI
Yaldigo 400 mg
100
k.A.
Gastric juice resistant tablets: Mesalazinum 400 mg
Tillotts Pharma AG
B
FB
G
IP
CI
Yaldigo 1600 mg
30
k.A.
Gastric juice resistant tablets: Mesalazinum 1600 mg
Tillotts Pharma AG
B
FB
G
IP
CI
Yaldigo 1600 mg
90
k.A.
Gastric juice resistant tablets: Mesalazinum 1600 mg
Tillotts Pharma AG
B
FB
G
IP
CI
Yaldigo 800 mg
30
k.A.
magensaftesistente Tablette: Mesalazinum 800 mg
Tillotts Pharma AG
B
FB
G
IP
CI
Yaldigo 800 mg
90
k.A.
magensaftesistente Tablette: Mesalazinum 800 mg
Tillotts Pharma AG
B
FB
G
Antidiarrheal Microorganisms (A07F) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
CI
Colibiogen oral
100 ml
k.A.
Solution (oral): Escherichiae coli Lysatum (Stamm Laves) 760-870 mg/ml
Laves-Arzneimittel
Gesellschaft mit
beschränkter Haftung,
Ronnenberg,
Zweigniederlassung
Schötz
D
FB
G
Other Antidiarrheals (A07X) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
Sidroga Durchfalltee
20 x 0.2 g
k.A.
Arzneitee: Agrimoniae Herba (Agrimonia Eupatoria l., Herba) 1.5 g
Uriach Switzerland AG
E
FB
G
Albumin Tannate, Combinations (A07XA51) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Geli-Stop
50 Tablet(s)
15.90
k.A.
Tablets: 3 Active Agents
Tentan AG
D
FB
G
(A07XZ) 3 products
WHO-DDD
Page 1 of 2:
1
2
>>
CI
H
Apo-Enterit
10 g
10.50
k.A.
Globules: 4 Active Agents
ebi-pharm ag
D
FB
G
CI
H
Apo-Enterit
50 ml
15.70
k.A.
Drops: 4 Active Agents
ebi-pharm ag
D
FB
G
CI
H
Dr. Reckeweg R 4
Enterocolin
50 ml
k.A.
gouttes buvables: 6 Active Agents
Laboratoire Jacques
Reboh et fils SA
D
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home